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Reply to Merz et al.
To the Editor:
The “ASHG “Statement on Professional Disclosure of
Familial Information” is the result of 2 year’s work and
consultation. While relying on both the President’s Com-
mission and I.O.M. reports, it also examined the issue
from an international, comparative perspective.
The literature and cases cited were but examples of a
growing realization that genetic information is not only
personal but necessarily familial. Reiterating and rein-
forcing the ethics of physician-patient confidentiality
formed the basis of our statement. The ethical-legal priv-
ilege of disclosure may be exercised if certain conditions
are met.
It is in the decision to respect (or not respect) the
patient’s refusal to allow disclosure that the health pro-
fessional, like all professionals, enjoys the concomitant
freedoms and responsibilities inherent in that very status.
The statement provides a framework not only for re-
flection and guidance in complex situations but also for
human reactions that cannot always be foreseen or con-
tractually arranged by consent or refusal prior to the
availability of test results.
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LOD Scores, Location Scores, and X-Linked Cone
Dystrophy
To the Editor:
In a previous issue of the Journal, Bergen and Pinckers
(1997) described a novel locus for X-linked progressive
cone dystrophy, on Xq27, which was assigned in a single
large pedigree. However, there appear to be two weak-
nesses in the data presented.
First, there is an apparent anomaly in the LOD scores
obtained for the family showing linkage. The most sig-
nificant two-point LOD score was only 2.6; yet, mul-
tipoint linkage analysis gave a LOD score of 10.8. Mul-
tipoint analysis functions to combine data from those
parts of the family that were uninformative for one or
more markers into a maximally informative haplotype.
As such, a multipoint analysis seems unlikely to give a
result so much larger than the two-point LOD scores
for the markers used to calculate it. As a rough rule of
thumb, when estimating the LOD score that a pedigree
should give, each informative meiotic event contributes
∼0.33 to the LOD score, if no recombination occurs.
Examination of the pedigree studied by Bergen and
Pinckers (1997) revealed 14 meioses informative for the
disease, which, on the basis described above, should give
at best a maximum LOD score of ∼4.6. I, therefore,
repeated the analysis described in their article, using the
alleles given. By assuming equal frequencies, I obtained
results similar to those given in table 3 of their article.
On the basis of the multipoint analysis, however, the
graph shown in figure 2 of their article evidently is in
fact a plot of location scores (the natural log) rather
than of LOD scores (log10). To obtain the LOD score,
the location score is divided by 4.6. Therefore, the true
LOD score obtained from this analysis was 2.35, not
10.8.
Although not stated by Bergen and Pinckers (1997),
I assumed that the markers presented in table 3 of their
article are in the order in which they occur on the chro-
mosome. If this is the case, then markers DXS297 and
DXS998 lie in the 3-cM gap between DXS292 and
DXS1123. Under that assumption and, again, when
equal allele frequencies were assumed, my multipoint
analysis with the alleles shown for markers DXS292,
DXS297, DXS998, DXS1123, and DXS1113 gave a
maximum LOD score of 3.38, at DXS998. Repetition
of this analysis, with allele frequencies estimated from
the six unrelated chromosomes sampled in the family,
gave a LOD score of only 2.46. In conclusion, these data
do indeed suggest a locus for X-linked cone dystrophy
in this region but with rather less significance than Ber-
gen and Pinckers have stated.
A second weakness in the article is the assertion that
this locus maps to Xq27. An examination of published
maps of the area (NIH/CEPH Collaborative Mapping
Group 1992; Gyapay et al. 1994) provides some infor-
mation but does not confirm a location on Xq27.
DXS292 and DXS297, which mark the proximal bound-
ary of the interval, are placed in Xq27-28, whereas
DXS998, which is within the interval, is only 3 cM from
the distal tip of the 1994 Ge´ne´thon X-chromosome map
(Gyapay et al. 1994). As such, for this locus, placement
on Xq28 seems equally likely, which would place the
locus in very close proximity to the red and green opsin
genes (RCP and GCP, respectively).
In table 1 of their article, Bergen and Pinckers (1997)
summarize the phenotypes resulting from the GCP and
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RCP mutations reported by Nathans et al. (1989) to
cause reduced visual acuity but with normal fundus. In
fact, figure 2 in the article by Nathans et al. (1989) shows
a fundus photograph from a patient with “progressive
bilateral central retinal degeneration” (p. 832). Other
patients are described as having macular lesions and at-
rophy, on ophthalmic examination. Therefore, a phe-
notype such as the one Bergen and Pinckers observed in
this family evidently could result from a mutation or
combination of mutations in the red- and green-pigment
genes. In these circumstances, exclusion of these genes
is essential before a new locus is assigned.
Bergen and Pinckers do indeed describe a multipoint
analysis using markers DXS8103 and DXS8069, ap-
parently spanning the RCP and GCP genes, that excludes
these genes. However, this evidence is given as “data not
shown,” no LOD scores for these markers are included
in table 3, and no reference is given to a published map
proving that these markers span the genes in question.
Furthermore, the authors’ assertion that “Southern blot
analysis with an RCP/GCP cDNA probe)did not reveal
any structural abnormalities” (Bergen and Pinckers
1997, p. 1,472) surely is insufficient, since abnormalities
at this locus can result from point mutations or from
rearrangements 4-kb upstream of the red cone–pigment
gene and 43-kb upstream of the green cone–pigment
gene. Therefore, although data excluding the RCP/GCP
locus in this family may exist, this could not be proved
on the basis of the results presented.
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Swyer Syndrome and 46,XY Partial Gonadal
Dysgenesis Associated with 9p Deletions in the
Absence of Monosomy-9p Syndrome
To the Editor:
Sex determination in humans depends on the function
of the SRY (sex-determining region, Y) gene. This gene
consists of a single exon located on the short arm of the
Y chromosome and encodes a protein that has a con-
served domain shared by the high-mobility–group nu-
clear proteins and various transcription factors (Sinclair
et al. 1990). The SRY protein has DNA-binding and
DNA-bending activities, suggesting that it may be a tran-
scription factor that controls the expression of down-
stream genes involved in sex determination and/or
differentiation (Pontiggia et al. 1994). Swyer syndrome
is characterized by a female phenotype and gonadal dys-
genesis leading to a streak gonad, in an individual with
a 46,XY chromosome complement (MIM 306100). Af-
fected individuals have normal stature and do not have
Turner stigmata (German 1970). Approximately 15%
of these cases have mutations in the SRY gene. Dupli-
cations of the locus DSS (dosage-sensitive sex reversal)
at Xp21.3 also are associated with 46,XY gonadal dys-
genesis; however, duplications of Xp are uncommon in
46,XY females (Veitia et al. 1997a). The etiology of the
majority of cases is unknown.
Partial monosomy of 9p (MIM 158170) is associated
with a syndrome characterized by mental retardation;
trigonocephaly; upward-slanting palpebral fissures;
short, broad, and webbed neck; flat nasal bridge; an-
teverted nostrils; and long philtrum (Alfi et al. 1973;
Huret et al. 1988). The presence of ambiguous genitalia
has been reported in 70% of XY individuals monosomic
for 9p (De Grouchy and Turleau 1982, pp. 162–167;
Schinzel 1984). In addition, an increasing number of
reports describe 46,XY partial or complete gonadal-dys-
genesis cases associated with deletions of 9p and pre-
senting with dysmorphic features due to either the de-
letion syndrome or the presence of a trisomic segment
(Bennett et al. 1993; Ogata et al. 1997; Veitia et al.
1997b; MIM 273350). In three of these cases, the break-
points have been defined at a molecular level, with the
smallest deleted region distal to D9S144 (Veitia et al.
